Purpose: To develop a radiomics nomogram based on computed tomography (CT) images that can help differentiate lung adenocarcinomas and granulomatous lesions appearing as sub-centimeter solid nodules (SCSNs). Materials and methods: The records of 214 consecutive patients with SCSNs that were surgically resected and histologically confirmed as lung adenocarcinomas (n = 112) and granulomatous lesions (n = 102) from 2 medical institutions between October 2011 and June 2019 were retrospectively analyzed. Patients from center 1 ware enrolled as training cohort (n = 150) and patients from center 2 were included as external validation cohort (n = 64), respectively. Radiomics features were extracted from non-contrast chest CT images preoperatively. The least absolute shrinkage and selection operator (LASSO) regression model was used for radiomics feature extraction and radiomics signature construction. Clinical characteristics, subjective CT findings, and radiomics signature were used to develop a predictive radiomics nomogram. The performance was examined by assessment of the area under the receiver operating characteristic curve (AUC). Results: Lung adenocarcinoma was significantly associated with an irregular margin and lobulated shape in the training set (p = 0.001, < 0.001) and external validation set (p = 0.016, = 0.018), respectively. The radiomics signature consisting of 22 features was significantly associated with lung adenocarcinomas of SCSNs (p < 0.001). The radiomics nomogram incorporated the radiomics signature, gender and lobulated shape. The AUCs of combined model in the training and external validation dataset were 0.885 (95% confidence interval [CI]: 0.823–0.931), 0.808 (95% CI: 0.690–0.896), respectively. Decision curve analysis (DCA) demonstrated that the radiomics nomogram was clinically useful. Conclusion: A radiomics signature based on non-enhanced CT has the potential to differentiate between lung adenocarcinomas and granulomatous lesions. The radiomics nomogram incorporating the radiomics signature and subjective findings may facilitate the individualized, preoperative treatment in patients with SCSNs.
The carotid web is commonly found in the carotid bulb or the beginning of the internal carotid artery. It presents as a thin layer of proliferative intimal tissue originating from the arterial wall and extending into the vessel lumen. A large body of research has proven that the carotid web is a risk factor for ischemic stroke. This review summarizes the current research status of the carotid web and focuses on its imaging presentation.
Purpose: To explore the application value of a multimodal deep learning radiomics (MDLR) model in predicting the risk status of postoperative progression in solid stage I non-small cell lung cancer (NSCLC). Materials and Methods: A total of 459 patients with histologically confirmed solid stage I NSCLC who underwent surgical resection in our institution from January 2014 to September 2019 were reviewed retrospectively. At another medical center, 104 patients were reviewed as an external validation cohort according to the same criteria. A univariate analysis was conducted on the clinicopathological characteristics and subjective CT findings of the progression and non-progression groups. The clinicopathological characteristics and subjective CT findings that exhibited significant differences were used as input variables for the extreme learning machine (ELM) classifier to construct the clinical model. We used the transfer learning strategy to train the ResNet18 model, used the model to extract deep learning features from all CT images, and then used the ELM classifier to classify the deep learning features to obtain the deep learning signature (DLS). A MDLR model incorporating clinicopathological characteristics, subjective CT findings and DLS was constructed. The diagnostic efficiencies of the clinical model, DLS model and MDLR model were evaluated by the area under the curve (AUC). Results: Univariate analysis indicated that size ( p = 0.004), neuron-specific enolase (NSE) ( p = 0.03), carbohydrate antigen 19 − 9 (CA199) ( p = 0.003), and pathological stage ( p = 0.027) were significantly associated with the progression of solid stage I NSCLC after surgery. Therefore, these clinical characteristics were incorporated into the clinical model to predict the risk of progression in postoperative solid-stage NSCLC patients. A total of 294 deep learning features with nonzero coefficients were selected. The DLS in the progressive group was (0.721 ± 0.371), which was higher than that in the nonprogressive group (0.113 ± 0.350) ( p < 0.001). The combination of size、NSE、CA199、pathological stage and DLS demonstrated the superior performance in differentiating postoperative progression status. The AUC of the MDLR model was 0.885 (95% confidence interval [CI]: 0.842–0.927), higher than that of the clinical model (0.675 (95% CI: 0.599–0.752)) and DLS model (0.882 (95% CI: 0.835–0.929)). The DeLong test and decision in curve analysis revealed that the MDLR model was the most predictive and clinically useful model. Conclusion: MDLR model is effective in predicting the risk of postoperative progression of solid stage I NSCLC, and it is helpful for the treatment and follow-up of solid stage I NSCLC patients. Graphical
To develop and validate a deep learning nomogram (DLN) model constructed from non-contrast computed tomography (CT) images for discriminating minimally invasive adenocarcinoma (MIA) from invasive adenocarcinoma (IAC) in patients with subsolid pulmonary nodules (SSPNs). In total, 365 consecutive patients who presented with SSPNs and were pathologically diagnosed with MIA or IAC after surgery, were recruited from two medical institutions from 2016 to 2019. Deep learning features were selected from preoperative CT images using convolutional neural network. Deep learning signature (DLS) was developed via the least absolute shrinkage and selection operator (LASSO). New DLN integrating clinical variables, subjective CT findings, and DLS was constructed. The diagnostic efficiency and discriminative capability were analyzed using the receiver operating characteristic method and decision curve analysis (DCA). In total, 18 deep learning features with non-zero coefficients were enrolled to develop the DLS, which was statistically different between the MIA and IAC groups. Independent predictors of DLS and lobulated sharp were used to build the DLN. The areas under the curves of the DLN were 0.889 (95% confidence interval (CI): 0.824-0.936), 0.915 (95% CI: 0.846-0.959), and 0.914 (95% CI: 0.848-0.958) in the training, internal validation, and external validation cohorts, respectively. After stratification analysis and DCA, the DLN showed potential generalization ability. The DLN incorporating the DLS and subjective CT findings have strong potential to distinguish MIA from IAC in patients with SSPNs, and will facilitate the suitable treatment method selection for the management of SSPNs.
In the postoperative management of early-stage non-small cell lung cancer (NSCLC), accurate identification of patients at high risk of progression is essential for developing personalized follow-up schedules and adjuvant treatment strategies. However, in multi-center settings, model and data heterogeneity limit the flexibility and generalizability of traditional federated learning. To address this, we propose a heterogeneous federated learning model (HFLM) that enables centers to adopt different model architectures while using a robust feature transfer strategy to alleviate the impact of heterogeneous data. Using CT images from 892 early-stage NSCLC patients across four medical institutions, HFLM achieved AUCs of 0.863 (95% CI, 0.8072–0.9192), 0.837 (95% CI, 0.7204–0.9530), 0.846 (95% CI, 0.7349–0.9564), and 0.847 (95% CI, 0.6971–0.9963). Cross-validation and stratified analyses further confirm its strong generalization and stability across centers.